Nadia Howlader
Impact in
- Oncology top 0.2%
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Colorectal Cancer Screening and Detection
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 25
- Global Cancer Incidence and Screening 17
- Cancer Risks and Factors 6
- COVID-19 and healthcare impacts 4
- Colorectal Cancer Screening and Detection 3
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 3
- Co-authors
- Brenda K. Edwards (5 shared papers)Angela B. Mariotto (20 shared papers)Lynn A. G. Ries (6 shared papers)Eric J. Feuer (6 shared papers)Matthew J. Hayat (2 shared papers)Kathleen A. Cronin (19 shared papers)Milton P. Eisner (1 shared paper)Marie‐Josèphe Horner (1 shared paper)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (10 papers)JNCI Journal of the National Cancer Institute (9 papers)Cancer (6 papers)JNCI Monographs (3 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesPortugalSouth Africa
In The Last Decade
Nadia Howlader
50 papers receiving 18.9k citations
Nadia Howlader's Hit Papers
Peers
Comparison fields: 5 of 180
- Oncology 6.4k
- Cancer Research 2.5k
- Pulmonary and Respiratory Medicine 3.5k
- Hematology 918
- Otorhinolaryngology 326
Countries citing papers authored by Nadia Howlader
This map shows the geographic impact of Nadia Howlader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Howlader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Howlader more than expected).
Fields of papers citing papers by Nadia Howlader
This network shows the impact of papers produced by Nadia Howlader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Howlader. The network helps show where Nadia Howlader may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadia Howlader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SEER Cancer Statistics Review, 1975-2003 Hit paper breakdown → | 2006 | 8445 |
| 2 | SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD Hit paper breakdown → | 2011 | 1334 |
| 3 | Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics Hit paper breakdown → | 2018 | 1274 |
| 4 | The Effect of Advances in Lung-Cancer Treatment on Population Mortality Hit paper breakdown → | 2020 | 1253 |
| 5 | US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status Hit paper breakdown → | 2014 | 1179 |
| 6 | Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program Hit paper breakdown → | 2007 | 877 |
| 7 | The Decrease in Breast-Cancer Incidence in 2003 in the United States Hit paper breakdown → | 2007 | 775 |
| 8 | Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State Hit paper breakdown → | 2015 | 758 |
| 9 | Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs Hit paper breakdown → | 2008 | 516 |
| 10 | Differences in Breast Cancer Survival by Molecular Subtypes in the United States Hit paper breakdown → | 2018 | 441 |
| 11 | 2010 | 388 | |
| 12 | 2016 | 333 | |
| 13 | Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients Hit paper breakdown → | 2019 | 292 |
| 14 | 2014 | 234 | |
| 15 | 2004 | 141 | |
| 16 | 2016 | 137 | |
| 17 | 2011 | 119 | |
| 18 | 2005 | 94 | |
| 19 | 2014 | 79 | |
| 20 | 2011 | 77 |
About Nadia Howlader
Nadia Howlader is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 52 papers that have together received 19.5k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (17 papers), Breast Cancer Treatment Studies (8 papers), Cancer Risks and Factors (6 papers), Multiple and Secondary Primary Cancers (4 papers), COVID-19 and healthcare impacts (4 papers), Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Screening and Detection (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (6.4k citations), Cancer Research (2.5k citations), Pulmonary and Respiratory Medicine (3.5k citations), Hematology (918 citations) and Otorhinolaryngology (326 citations). Nadia Howlader has collaborated with scholars based in United States, Portugal and South Africa. Frequent co-authors include Brenda K. Edwards, Angela B. Mariotto, Lynn A. G. Ries, Eric J. Feuer, Matthew J. Hayat, Kathleen A. Cronin, Milton P. Eisner, Marie‐Josèphe Horner, Martin F. Krapcho and Benjamin F. Hankey. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, JNCI Journal of the National Cancer Institute, Cancer, JNCI Monographs and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.